Related Experiment Video
Updated: Dec 16, 2025

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Remote Ischemic Conditioning in Patients with Acute Coronary Syndromes: A Systematic Review with Meta-Analysis and
Irene Sandven1, Jan Eritsland2, Michael Abdelnoor3,4
1Oslo Centre for Biostatistics and Epidemiology (OCBE), Oslo University Hospital, Oslo, Norway.
Remote ischemic conditioning (RIC) did not significantly reduce mortality, myocardial infarction, or heart failure in acute coronary syndrome patients undergoing percutaneous coronary intervention. This systematic review found no beneficial effect of RIC in this patient population.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Trials
Background:
- Acute coronary syndromes (ACS) represent a significant cause of morbidity and mortality.
- Percutaneous coronary intervention (PCI) is a primary treatment for ACS.
- Remote ischemic conditioning (RIC) is a potential cardioprotective strategy.
Purpose of the Study:
- To evaluate the efficacy of remote ischemic conditioning (RIC) compared to no conditioning.
- To assess the impact of RIC on clinical endpoints in patients with ACS undergoing PCI.
Main Methods:
- Systematic review and meta-analysis of 13 randomized clinical trials (RCTs) including 7183 patients.
- Literature search up to September 13, 2019.
- Analysis of endpoint mortality, myocardial infarction (MI), and congestive heart failure (CHF) using rate ratios (RR) and confidence intervals (CI).
- Evaluation of small-study effects and risk of false-positive results using trim-and-fill and trial sequential analysis (TSA).
Main Results:
- RIC did not significantly reduce endpoint mortality (RR=0.81, 95% CI: 0.56-1.17) or myocardial infarction (RR=0.85, 95% CI: 0.62-1.18).
- No significant effect was observed for congestive heart failure (RR=0.71, 95% CI: 0.44-1.15).
- Controlling for small-study effects confirmed the lack of efficacy for RIC.
Conclusions:
- Current evidence from this systematic review indicates that RIC offers no significant benefit for clinical endpoints in ACS patients undergoing PCI.
- RIC did not demonstrate efficacy in reducing mortality, MI, or CHF during a median 1-year follow-up.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease V: Interprofessional Care